This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novelty Nobility Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jin-Ock Kim: Innovator in Anti-C-KIT Antibody Development
Introduction
Jin-Ock Kim is a prominent inventor based in Jeungpyeong-gun, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His innovative work focuses on addressing angiogenesis-related diseases, which are critical in various health conditions.
Latest Patents
Jin-Ock Kim holds a patent for a novel anti-C-KIT antibody. This invention relates to an anti-C-KIT antibody or an antibody fragment that can be utilized in medical treatments. The patent also includes a composition for preventing or treating angiogenesis-related diseases, as well as a diagnostic kit for these conditions. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Jin-Ock Kim is associated with Novelty Nobility Inc., where he continues to work on innovative solutions in biotechnology. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research. His dedication to his work is evident in the quality and impact of his inventions.
Collaborations
One of his notable collaborators is Sang Gyu Park. Together, they work on various projects that aim to enhance the understanding and treatment of diseases related to angiogenesis. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Jin-Ock Kim is a distinguished inventor whose work on the anti-C-KIT antibody represents a significant advancement in biotechnology. His contributions have the potential to improve the diagnosis and treatment of angiogenesis-related diseases, showcasing the impact of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile